J. Bruhwyler

发表

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study

S. Weisnagel, C. Mathieu, P. Stella, 2020, Diabetes Therapy.

Potential use of a radioreceptor assay for the determination of benzodiazepine compounds in serum.

J. Bruhwyler, A. Hassoun, 1993, Journal of analytical toxicology.

A LARGE, OPEN-LABEL TRIAL OF NIMESULIDE IN PATIENTS WITH OSTEOARTICULAR CONDITIONS TREATED IN A GENERAL PRACTICE SETTING

J. Famaey, J. Bruhwyler, K. Vandekerckhove, 1998 .

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine

G. Leroux-Roels, P. Moris, I. Leroux-Roels, 2022, Frontiers in Immunology.

OPEN CONTROLLED RANDOMIZED MULTICENTER COMPARISON OF NIMESULIDE AND DICLOFENAC IN THE TREATMENT OF SUBACUTE AND CHRONIC LOW BACK PAIN

T. Appelboom, J. Famaey, J. Bruhwyler, 1998 .

Clozapine: An atypical neuroleptic

J. Bruhwyler, E. Chleide, M. Mercier, 1990, Neuroscience & Biobehavioral Reviews.

Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers

H. Jacobs, J. Bruhwyler, F. Carreer, 2009, International journal of food sciences and nutrition.

Comorbidities and survival in patients with chronic hypersensitivity pneumonitis

M. Kreuter, J. Morisset, K. Johannson, 2020, Respiratory Research.

Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: application to antipsychotic drugs.

H. Meltzer, J. Liégeois, J. Kauffmann, 1999, Archives of biochemistry and biophysics.

The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates

J. Liégeois, D. Casey, J. Bruhwyler, 2001, Psychopharmacology.

Dopamine D4 selective ligands as potential antipsychotics

J. Liégeois, J. Bruhwyler, 1997 .

Effects of a long-interval retention on the hypoxia-induced impairment of performance in a fixed-interval schedule

J. Bruhwyler, E. Chleide, M. Mercier, 1993, Behavioural Brain Research.

Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina

J. Famaey, R. Messin, J. Bruhwyler, 2006, Advances in therapy.

Enhanced resistance effect of piracetam upon hypoxia-induced impaired retention of fixed-interval responding in rats

J. Bruhwyler, E. Chleide, M. Mercier, 1991, Pharmacology Biochemistry and Behavior.

Efficacy of 2LPAPI®, a Micro-Immunotherapy Drug, in Patients with High-Risk Papillomavirus Genital Infection

G. Thomas, B. Lejeune, J. Bruhwyler, 2016 .

Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats

J. Liégeois, J. Legros, J. Bruhwyler, 2002, Neuroscience Letters.

JL 13, a potential successor to clozapine, is less sensitive to oxidative phenomena.

J. Liégeois, J. Kauffmann, A. Mouithys-Mickalad, 1997, Biochemical and biophysical research communications.

Multicentric open-label study of the efficacy and tolerability of citicoline in the treatment of acute cerebral infarction

J. Bruhwyler, J. Géczy, J. V. Dorpe, 1997 .

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

P. Mintz, P. Rebulla, G. Escolar, 2010, Transfusion.

Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.

J. Liégeois, T. P. Nguyen, J. Bruhwyler, 1994, Journal of medicinal chemistry.

Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues.

H. Wikström, G. Deby-dupont, J. Liégeois, 2001, Journal of medicinal chemistry.

JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties.

H. Meltzer, J. Liégeois, J. Bergman, 1997, Pharmacological research.

Diarylazepine Derivatives as Potent Atypical Neuroleptic Drugs: Recent Advances

J. Liégeois, J. Bruhwyler, J. Delarge, 1995, Current Medicinal Chemistry.

New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study.

J. Liégeois, T. P. Nguyen, J. Bruhwyler, 1993, Journal of medicinal chemistry.

Nitric oxide: A new messenger in the brain

J. Liégeois, J. Bruhwyler, E. Chleide, 1993, Neuroscience & Biobehavioral Reviews.

The inclusion of fluoxetine into γ-cyclodextrin increases its bioavailability: behavioural, electrophysiological and pharmacokinetic studies

J. Scuvée-Moreau, A. Dresse, L. Szente, 2000, Psychopharmacology.

Effects of low doses of neuroleptics on temporal regulation in a differential reinforcement of response duration (DRRD) schedule in the dog

J. Bruhwyler, E. Chleide, M. Mercier, 1990, Pharmacology Biochemistry and Behavior.

Double‐blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression

B. Brichard, J. Bruhwyler, J. Géczy, 1997, Acta psychiatrica Scandinavica.

A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus

T. Monath, G. Leroux-Roels, D. Pinschewer, 2020, The Journal of infectious diseases.

Stimulant effect of the β-carboline FG 7142 in the open-field test

G. Houbeau, J. Bruhwyler, E. Chleide, 1991 .

Comparative study of the behavioral, neurophysiological, and motor effects of psychotropic drugs in the dog

J. Bruhwyler, E. Chleide, 1990, Biological Psychiatry.

Efficacy of a Novel Antibody TLR3 Modulator in the Self-Treatment of Common Cold: The ESTUAR Trial

M. Thiry, J. Bruhwyler, A. Martyushev-Poklad, 2015 .

A large open trial of proglumetacin in the treatment of soft-tissue rheumatisms

J. Famaey, J. Bruhwyler, A. Brodsky, 1994 .

Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.

B. Masereel, J. Liégeois, B Masereel, 1995, European journal of pharmacology.

Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.

A. Cools, B. Ellenbroek, J. Liégeois, 2001, The Journal of pharmacology and experimental therapeutics.

Effect of chronic hypoxic treatment on the retention of fixed-interval responding

J. Bruhwyler, E. Chleide, M. Mercier, 1991, Physiology & Behavior.

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis

A. Warth, F. Herth, C. Heussel, 2016, PloS one.

Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study

I. Colin, A. Scheen, A. Verhaegen, 2020, Diabetes Therapy.

The use of radioreceptor assays for the determination of benzodiazepines in biological samples: a review.

J. Bruhwyler, A. Hassoun, 1992, Journal of analytical toxicology.

Anxiolytic potential of a microgram dose of chlordiazepoxide in the open-field test.

J. Bruhwyler, 1990, European journal of pharmacology.

Facilitatory effects of chronically administered citicoline on learning and memory processes in the dog

J. Liégeois, J. Bruhwyler, J. Géczy, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.

Y. Karpov, R. Messin, J. Bruhwyler, 1998, Journal of cardiovascular pharmacology.

Amineptine improves the performance of dogs in a complex temporal regulation schedule

M. Rettori, J. Bruhwyler, E. Chleide, 1993, Pharmacology Biochemistry and Behavior.

Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.

G. Brusselle, R. Peché, P. Van den Brande, 2012, Respiratory medicine.

A double‐blind randomized placebo‐controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression

J. Wilde, J. Bruhwyler, J. Géczy, 1996, Acta psychiatrica Scandinavica.

Double‐Blind Randomized Controlled Pilot Study of the Efficacy and Tolerability of Pirlindole, a Reversible Inhibitor of Monoamine Oxidase A, and Mianserin, in the Treatment of Depression

C. Mertens, J. Bruhwyler, J. Géczy, 1997 .

Differentiation of haloperidol and clozapine using a complex operant schedule in the dog

G. Houbeau, J. Bruhwyler, E. Chleide, 1993, Pharmacology Biochemistry and Behavior.

Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test

J. Liégeois, J. Bruhwyler, E. Chleide, 1990, Pharmacology Biochemistry and Behavior.

Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine

L. Stergiou, P. Lambert, G. Leroux-Roels, 2023, Vaccines.

Hypochlorous Acid, a Major Oxidant Produced by Activated Neutrophils, Has Low Effect on Two Pyridobenzazepine Derivatives, JL 3 and JL 13

J. Liégeois, J. Uetrecht, N. Zahid, 2000, Archiv der Pharmazie.

New dibenzazepine derivatives with disinhibitory and/or antidepressant potential: neurochemical and behavioural study in the open‐field and forced swimming tests

J. Liégeois, J. Bruhwyler, J. Géczy, 1995, Behavioural pharmacology.

Comparative study of typical neuroleptics, clozapine and newly synthesized clozapine‐analogues: correlations between neurochemistry and behaviour

J. Liégeois, J. Bruhwyler, M. Mercier, 1992, Behavioural pharmacology.

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial.

G. Leroux-Roels, Yorick Janssens, I. Leroux-Roels, 2023, The Lancet. Infectious diseases.

Effects of specific dopaminergic agonists and antagonists in the open-field test

J. Liégeois, J. Bruhwyler, E. Chleide, 1991, Pharmacology Biochemistry and Behavior.

Transformation of a waiting schedule into a temporal regulation schedule (DRRD) by addition of external stimuli in the dog

J. Bruhwyler, E. Chleide, M. Mercier, 1988, Behavioural Processes.

Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties.

J. Liégeois, J. Bruhwyler, J. Géczy, 1997, Pharmacological research.

Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.

G. Brusselle, R. Peché, P. Van den Brande, 2012, Respiratory medicine.